ApaTech gains US thumps-up for flagship product
This article was originally published in Clinica
In what allows it to take its lead product to the US market, UK orthopaedics firm ApaTech has gained FDA clearance for its synthetic bone graft substitute, ApaPore.
You may also be interested in...
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.
Vydaqel saw its uptake take off in the US last year. UK’s NICE to pass judgement on cost effectiveness by June.
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.